Xiaowen specialises in M&A transactions and corporate law structuring of national and international companies. She has particular expertise in the area of corporate transactions and structuring in the healthcare sector, is familiar with the specifics of the highly regulated healthcare sector and has excellent networks there.

Of particular note are the approximately 60 M&A transactions for the creation of medical care centre groups as well as nine clinic transactions which underline her successful track record for ongoing advice to various corporate groups. On the product side, Xiaowen is also an experienced legal adviser with medtech, biotech and pharmaceutical transactions, including digital health investments. As a native Chinese speaker and member of the China Group, Xiaowen also advises Chinese companies and investors on outbound activities in Germany and Europe.
Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Word on the street at the J.P. Morgan Healthcare Conference 2023

1 février 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus
Brevets et innovation

The UPC's top 10 defining decisions

17 juin 2024

par Dr Paul England

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Court of Appeal in Ireland grants interlocutory injunction restraining the launch of Teva’s generic apixaban product pending determination of appeal

14 juin 2024
Briefing

par Eoin Martyn

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Taylor Wessing a conseillé MPH Energie et Isatis Capital dans le cadre de l’acquisition de FPS

13 juin 2024

par plusieurs auteurs

Cliquer ici pour en savoir plus